Cart
sales@molnova.com
Merodantoin
CAS No. 143413-73-4
Merodantoin ( —— )
Catalog No. M27994 CAS No. 143413-73-4
Merodantoin is an apoptosis inducer and triggers cell apoptosis associated with ROS-dependent autophagy. Merodantoin targets cancer cells expressing KRAS mutations involved in Akt-dependent ROS production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMerodantoin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMerodantoin is an apoptosis inducer and triggers cell apoptosis associated with ROS-dependent autophagy. Merodantoin targets cancer cells expressing KRAS mutations involved in Akt-dependent ROS production.
-
DescriptionMerodantoin is an apoptosis inducer and triggers cell apoptosis associated with ROS-dependent autophagy. Merodantoin targets cancer cells expressing KRAS mutations involved in Akt-dependent ROS production.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
Recptorcereblon (CRBN) E3 ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number143413-73-4
-
Formula Weight242.3
-
Molecular FormulaC11H18N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCN1C(=O)C(=O)N(CCCC)C1=S
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.David Proia, et al. Advantageous therapies for disorders mediated by ikaros or aiolos. WO2022032132A1.
molnova catalog
related products
-
Kinetin riboside
A cytokinin analog that displays potent antiproliferative activity against various human cancer cell lines.
-
NecroX-7
NecroX-7 is a small molecule necrosis modulator and potent antioxidant molecule.
-
Silvestrol
Silvestrol is a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in cancer cells through the mitochondrial/apoptosome pathway.
